News Insights from Dr. Adam J. Fein

2024-01-20T13:05:00.002-05:00

Drug Channel Entities Are Undergoing Raft of Changes Spotlight on Market Access

2024-01-18T15:21:00.005-05:00

CVS Removes Humira From Formulary — But the Fine Print Is Key AIS Health

2024-01-04T16:24:00.003-05:00

Expect Impact From Patient-Paid Prescriptions, GLP-1s to Continue, While PBM Business Models Remain Murky AIS Health

2023-12-05T07:05:00.004-05:00

CVS Plans to Overhaul How Much Drugs Cost The Wall Street Journal

2023-11-30T12:10:00.002-05:00

Cigna-Humana Merger Is Likely to Face Antitrust Challenge The Wall Street Journal

2023-11-30T12:05:00.000-05:00

Amazon Once Inspired Fear in the Health-Care Industry. No Longer Bloomberg

2023-11-03T07:54:00.004-04:00

Why Your Neighborhood Pharmacy Isn’t So Friendly Anymore The Wall Street Journal

2023-10-27T08:47:00.007-04:00

Rite Aid Bankruptcy Follows Years of PBM Misadventure Radar on Drug Benefits

2023-09-17T20:08:00.003-04:00

What CVS Stands to Gain by Setting Up Biosimilar Subsidiary Cordavis MedCity News

2023-09-01T11:37:00.002-04:00

Ohio senator says Medicare drug cost negotiations will save money. Others aren't so sure WSYX

2023-08-22T12:35:00.002-04:00

Drug Benefit Firms Devise New Fees That Go to Them, Not Clients Bloomberg

2023-08-17T13:12:00.004-04:00

CVS Health Dives As Blue Shield Of California Taps Mark Cuban, Amazon In Challenge To PBM Model Investor's Business Daily

2023-08-17T08:01:00.000-04:00

A Big Health Insurer Is Ripping Up the Playbook on Drug Pricing The Wall Street Journal

2023-08-01T14:36:00.004-04:00

Patients already paying price for PBMs diverting copay cash meant for needy ABC6

2023-07-13T15:09:00.000-04:00

PBMs Keep New Biosimilars on Equal Footing With Best-Selling Humira, Radar on Drug Benefits

2023-07-07T10:19:00.002-04:00

Accumulators, Maximizers, Alternative Funding Models Contribute to ‘Doom Loop of Specialty Drug Benefits’ AIS Health

2023-07-07T10:17:00.006-04:00

How to Beat the Rising Cost of Prescription Drugs Consumer Reports

2023-06-09T10:59:00.004-04:00

Average salaries for retail pharmacists grows for first time in three years MM+M

2023-06-01T17:43:00.002-04:00

Coherus works with Mark Cuban to sell biosimilar Humira at steep discounts STAT

2023-05-24T07:17:00.003-04:00

Caremark, Express Scripts and OptumRx dominate as top PBMs of 2022 MM+M

2023-05-08T09:38:00.003-04:00

Inflation Reduction Act, Cell and Gene Therapy Were Hot Topics at Asembia Meeting Managed Healthcare Executive

2023-05-08T08:00:00.004-04:00

Asembia 2023: An Active and Complex Future for Specialty Therapies CoverMyMeds

2023-05-03T18:53:00.004-04:00

Verma Talks About the ‘Pretty Toxic’ Environment of Trump Administration Managed Healthcare Executive

2023-03-27T12:35:00.002-04:00

Drug Middlemen Accused of Price Fixing by Ohio Attorney General The Wall Street Journal

2023-03-22T20:56:00.005-04:00

Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines STAT